Another anti-MM miRNA is miR-125b-5p, which was shown to exert tumor-suppressing activity in vitro and in vivo via direct targeting of the oncogenic IRF4 and its downstream effector, BLIMP-1. Here, IRF4 is linked to Miyoshi myopathy.